Gelonghui, January 9 | Goldman Sachs: Downgraded Amgen's Target Price from $375 to $370, maintaining a "Buy" rating. (Gelonghui)
高盛下调安进目标价至370美元
Goldman Sachs lowered Amgen's Target Price to $370.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated